Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
3/15/25 AbbVie (ABBV) Elahere for Ovarian Cancer Subscribers Only Subscribers Only Subscribers Only
3/12/25 GSK (GSK) VH109 for HIV / AIDS Treatment Subscribers Only Subscribers Only Subscribers Only
3/11/25 Arvinas (ARVN) Vepdegestrant for HR+/HER2- Breast Cancer Subscribers Only Subscribers Only Subscribers Only
3/10/25 Novo Nordisk (NVO) CagriSema for Obesity Subscribers Only Subscribers Only Subscribers Only
3/10/25 Johnson & Johnson (JNJ) Icotrokinra for Ulcerative Colitis (UC) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
12/31/2024 Subscribers Only Subscribers Only Regulatory - IND/CTA Filing
02/12/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
02/27/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
03/05/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
03/12/2025 Subscribers Only Subscribers Only Partnership - Acquisition Completion